A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC

Clinical trial NCT06637072 · COMPLETED

Trial details

NCT number: NCT06637072
Sponsor: argenx
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Inflammatory Demyelinating Polyneuropathy

Start date: 2024-12-10
Primary completion: 2026-02-19
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.